Sofinnova Investments, Inc.
CIK 1631134 · Holdings on Jun 30, 2024 · First reported Aug 9, 2024
Top ten holdings
Q2 2024- NTRA10.58%
- VERA6.37%
- ASND6.31%
- NVO5.84%
- EW4.22%
- SYK4.14%
- AZNN3.94%
- DYN3.62%
- ALGN3.32%
- RAPP2.86%
Share classes counted separately51.20%
Portfolio value by quarter
What changed this quarter?
Within preview · weight change- NTRAWeight increased · +2.21 pp8.37% → 10.58%Shares 0 (0.00%)
- AZNNWeight increased · +1.55 pp2.39% → 3.94%Shares +204.70K (+34.31%)
- ALGNWeight increased · +1.47 pp1.85% → 3.32%Shares +123.05K (+128.87%)
Weight = security value ÷ total reported holdings value. Changes are in percentage points; price moves also affect weights, so they are not trade sizes.
Top 10 holdings 25
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | NTRANATERA INC View history and evidence | $167.88M | 10.58% | 1.55M shares | 8.37% → 10.58%+2.21 pp 0 (0.00%) | Unchanged | ↗▾ |
| 02 | VERAVERA THERAPEUTICS INCCL A View history and evidence | $101.09M | 6.37% | 2.79M shares | 7.11% → 6.37%-0.74 pp 0 (0.00%) | Unchanged | ↗▾ |
| 03 | ASNDASCENDIS PHARMA A/SSPONSORED ADR View history and evidence | $100.14M | 6.31% | 734.28K shares | 6.73% → 6.31%-0.42 pp -19.75K (-2.62%) | Reduced | ↗▾ |
| 04 | NVONOVO-NORDISK A/S-SPONS ADRADR View history and evidence | $92.72M | 5.84% | 649.54K shares | 4.64% → 5.84%+1.20 pp +37.66K (+6.15%) | Added | ↗▾ |
| 05 | EWEDWARDS LIFESCIENCES CORP View history and evidence | $66.90M | 4.22% | 724.23K shares | Prior unavailable +724.23K | New | ↗▾ |
| 06 | SYKSTRYKER CORP View history and evidence | $65.70M | 4.14% | 193.08K shares | Prior unavailable +193.08K | New | ↗▾ |
| 07 | AZNNASTRAZENECA PLC-SPONS ADRSPONSORED ADR View history and evidence | $62.50M | 3.94% | 801.42K shares | 2.39% → 3.94%+1.55 pp +204.70K (+34.31%) | Added | ↗▾ |
| 08 | DYNDYNE THERAPEUTICS INC View history and evidence | $57.37M | 3.62% | 1.63M shares | 3.24% → 3.62%+0.38 pp -310.95K (-16.06%) | Reduced | ↗▾ |
| 09 | ALGNALIGN TECHNOLOGY INC View history and evidence | $52.76M | 3.32% | 218.52K shares | 1.85% → 3.32%+1.47 pp +123.05K (+128.87%) | Added | ↗▾ |
| 10 | RAPPRAPPORT THERAPEUTICS INC View history and evidence | $45.39M | 2.86% | 1.95M shares | Prior unavailable +1.95M | New | ↗▾ |
Options overlay 9
$337.24M notionalPut and Call positions are separate. Notional is based on underlying securities, not option premium, market value or net exposure. Quantities are underlying shares.
| Security | Put / Call | Underlying shares | Notional | Quantity change | |
|---|---|---|---|---|---|
QQQINVESCO QQQ TRUST SERIES 1UNIT SER 1 View history and evidence | Put | 400.00K | $191.64M | +400.00K | ▾ |
EWEDWARDS LIFESCIENCES CORP View history and evidence | Put | 500.00K | $46.19M | +500.00K | ▾ |
ABTABBOTT LABORATORIES View history and evidence | Call | 390.20K | $40.55M | +390.20K | ▾ |
3 / 9 options · preview only
Exited positions 13
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| MRK MERCK & CO. INC. | Non-derivative | -651,299 | -$85.94M | SEC filing ↗ | SEC filing ↗ |
| INCY INCYTE CORP | Non-derivative | -1,327,178 | -$75.61M | SEC filing ↗ | SEC filing ↗ |
| ARGX ARGENX SE - ADR | Non-derivative | -149,300 | -$58.78M | SEC filing ↗ | SEC filing ↗ |
3 / 13 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1631134 · Period 2024-06-30
Data loaded 2026-09-23 · First reported 2024-08-09
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 1924168403
}Research all 81 reported holdings.
This page includes 30 of 81 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 30 of 81 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1631134","quarter":"2024Q2","page_size":100}
get_institutional_manager_history
{"cik":"1631134","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.